1. Home
  2. Analysis
  3. Thiotepa
  4. Stem-cell-transplant

Thiotepa and Stem cell transplant - a phase IV clinical study of FDA data

Summary:

Stem cell transplant is reported as a side effect among people who take Thiotepa (thiotepa), especially for people who are female, 2-9 old, have been taking the drug for < 1 month also take Cyclophosphamide, and have Bone marrow conditioning regimen.

The phase IV clinical study analyzes which people have Stem cell transplant when taking Thiotepa. It is created by eHealthMe based on reports of 8,095 people who have side effects when taking Thiotepa from the FDA, and is updated regularly.

What is Thiotepa?

Thiotepa has active ingredients of thiotepa. eHealthMe is studying from 8,097 Thiotepa users. Check the latest studies of Thiotepa.

What is Stem cell transplant?

Stem cell transplant is found to be associated with 429 drugs and 386 conditions by eHealthMe. Check the latest studies of Stem cell transplant.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

8,095 people reported to have side effects when taking Thiotepa.
Among them, 67 people (0.83%) have Stem cell transplant.

Could Thiotepa cause Stem cell transplant?

Among these 67 people:

How long have people been on Thiotepa when they have Stem cell transplant? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Stem cell transplant when taking Thiotepa? *

  • female: 56.36 %
  • male: 43.64 %

What is the age of people who have Stem cell transplant when taking Thiotepa? *

  • 0-1: 7.27 %
  • 2-9: 34.55 %
  • 10-19: 29.09 %
  • 20-29: 7.27 %
  • 30-39: 7.27 %
  • 40-49: 5.45 %
  • 50-59: 9.09 %
  • 60+: 0.0 %

What are other drugs people take besides Thiotepa? *

  1. Cyclophosphamide: 22 people, 32.84%
  2. Carboplatin: 20 people, 29.85%
  3. Etoposide: 20 people, 29.85%
  4. Melphalan Hydrochloride: 10 people, 14.93%
  5. Methotrexate: 9 people, 13.43%
  6. Cisplatin: 8 people, 11.94%
  7. Busulfan: 8 people, 11.94%
  8. Fludarabine Phosphate: 7 people, 10.45%
  9. Melphalan: 6 people, 8.96%
  10. Mesna: 6 people, 8.96%

What are other side effects people have besides Stem cell transplant? *

  1. Mucosal Inflammation (infection of mucous membrane): 12 people, 17.91%
  2. Fever: 12 people, 17.91%
  3. Sepsis (a severe blood infection that can lead to organ failure and death): 11 people, 16.42%
  4. Diarrhea: 10 people, 14.93%
  5. Thrombocytopenia (decrease of platelets in blood): 8 people, 11.94%
  6. Hypotension (abnormally low blood pressure): 7 people, 10.45%
  7. Venoocclusive Liver Disease (small veins in the liver are obstructed): 6 people, 8.96%
  8. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 6 people, 8.96%
  9. Nausea And Vomiting: 6 people, 8.96%
  10. Disease Progression: 6 people, 8.96%

What are the existing conditions these people have? *

  1. Bone Marrow Conditioning Regimen: 8 people, 11.94%
  2. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 6 people, 8.96%
  3. Medulloblastoma (a fast-growing, high-grade tumour that always begins in the cerebellum): 6 people, 8.96%
  4. Hodgkin's Lymphoma (cancer originating from white blood cells): 3 people, 4.48%
  5. Central Nervous System Lymphoma (cancer of central nervous system forms in lymph tissue): 3 people, 4.48%
  6. Brain Neoplasm Malignant (brain cancer tumour): 3 people, 4.48%
  7. Metastases To Bone (cancer spreads to bone): 2 people, 2.99%
  8. Medulloblastoma Recurrent (reoccurrence of a fast-growing, high-grade tumour that always begins in the cerebellum): 2 people, 2.99%
  9. Primitive Neuroectodermal Tumor: 2 people, 2.99%
  10. Ewing's Sarcoma (malignant small, round, blue cell tumour): 2 people, 2.99%

* Approximation only. Some reports may have incomplete information.

Do you take Thiotepa and have Stem cell transplant?

- Check whether Stem cell transplant is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Thiotepa:

Stem cell transplant treatments and more:

How severe was Stem cell transplant and when was it recovered:

Expand to all the drugs that have ingredients of thiotepa:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Thiotepa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stem cell transplant:

Browse all the conditions that are associated with Stem cell transplant:

How the study uses the data?

The study uses data from the FDA. It is based on thiotepa (the active ingredients of Thiotepa) and Thiotepa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.